Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
The disease is cause by mutations or imprinting defects in the GNAS1 gene. The syndrome is characterized by pseudohypoparathyroidism and skeletal abnormalities associated sometimes with mental retardation.
The clinical symptoms of Albright hereditary osteodystrophy (AHO) include pseudohypoparathyroidism (PHP) (renal parathyroid hormone resistance) and disturbances of skeletal development (short stature, obesity, round face, intramembranous ossifications, brachydactyly, and other). PTH resistance accounts for hypocalcemia and hyperphosphatemia which is not amenable to PTH treatment.
The imprinting mechanism of this gene brings about that the disease occurs only when it is passed by a mother with mild clinical symptoms or a de novo mutation of the maternal allele. If the mutation is paternally inherited the symptoms are usually milder and the laboratory findings (calcium and phosphate) are normal. This condition is named pseudopseudohypoparathyroidism (PPHP).
| Heterotopic Ossification | |
 |
In Albright hereditary osteodystrophy (AHO) subcutaneous ossifications are accompanied by hormone resistance and dysmorphic features. |
| 1. |
Simon A et al. (2000) Pseudohypoparathyroidism type Ia. Albright hereditary osteodystrophy: a model for research on G protein-coupled receptors and genomic imprinting. 
|
| 2. |
None (1997) Inborn errors of signal transduction: mutations in G proteins and G protein-coupled receptors as a cause of disease.
|
| 3. |
None (1997) The molecular basis of disorders caused by defects in G proteins.
|
| 4. |
Weinstein LS et al. (2004) Minireview: GNAS: normal and abnormal functions.
|
| 5. |
Levine MA et al. (2003) Genetic basis for resistance to parathyroid hormone.
|
| 6. |
None (2003) Cutaneous manifestations of endocrine disorders: a guide for dermatologists.
|
| 7. |
None (2002) Imprinting disorders: non-Mendelian mechanisms affecting growth.
|
| 8. |
Weinstein LS et al. (2002) Gs(alpha) mutations and imprinting defects in human disease.
|
| 9. |
Lania A et al. (2001) G protein mutations in endocrine diseases.
|
| 10. |
Weinstein LS et al. (2001) Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.
|
| 11. |
Kaplan FS et al. (2000) Progressive osseous heteroplasia.
|
| 12. |
Aldred MA et al. (2000) Activating and inactivating mutations in the human GNAS1 gene.
|
| 13. |
None (2000) G protein defects in signal transduction.
|
| 14. |
None (1999) Hormone resistance caused by mutations in G proteins and G protein-coupled receptors.
|
| 15. |
OMIM.ORG article Omim 103580
|
| 16. |
Orphanet article Orphanet ID 665
|
| 17. |
Wikipedia article Wikipedia EN (Albright's_hereditary_osteodystrophy)
|
 |
Copyright © 2005-2024 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944 Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits |
